271 related articles for article (PubMed ID: 7690985)
1. Clinical use of HCG and hCG beta determinations.
Mann K; Saller B; Hoermann R
Scand J Clin Lab Invest Suppl; 1993; 216():97-104. PubMed ID: 7690985
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of human chorionic gonadotropin and alpha-subunit measurements.
Hussa RO
Obstet Gynecol; 1982 Jul; 60(1):1-12. PubMed ID: 6283446
[TBL] [Abstract][Full Text] [Related]
3. Human chorionic gonadotropin in cancer.
Stenman UH; Alfthan H; Hotakainen K
Clin Biochem; 2004 Jul; 37(7):549-61. PubMed ID: 15234236
[TBL] [Abstract][Full Text] [Related]
4. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.
Marcillac I; Troalen F; Bidart JM; Ghillani P; Ribrag V; Escudier B; Malassagne B; Droz JP; Lhommé C; Rougier P
Cancer Res; 1992 Jul; 52(14):3901-7. PubMed ID: 1377600
[TBL] [Abstract][Full Text] [Related]
5. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
Kitajima T; Mochizuki M; Nishimura R
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
Zhang WY
Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
[TBL] [Abstract][Full Text] [Related]
7. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
Cole LA; Butler S
J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
[TBL] [Abstract][Full Text] [Related]
8. [The follow-up of trophoblastic disease by using an hCG-CTP enzyme immunoassay].
Matsuura Y; Kashimura M; Shinohara M; Baba S; Kondo M; Kashimura Y
Gan No Rinsho; 1990 Dec; 36(15):2559-62. PubMed ID: 2176247
[TBL] [Abstract][Full Text] [Related]
9. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
[TBL] [Abstract][Full Text] [Related]
10. [Beta-HCG positive seminoma--incidence with special reference to tumor marker concentration in testicular venous blood].
Mumperow E; Kressel K; Hartmann M
Urologe A; 1991 Mar; 30(2):114-6; discussion 117. PubMed ID: 1711727
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
12. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
[TBL] [Abstract][Full Text] [Related]
13. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
[TBL] [Abstract][Full Text] [Related]
14. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
15. [Newly developed enzyme immunoassay for hCG-beta CTP and its significance in follow-up practice of trophoblastic disease].
Sato Y; Sudo Y; Hirohashi T; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1079-86. PubMed ID: 2427625
[TBL] [Abstract][Full Text] [Related]
16. Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease.
Ozturk M
J Reprod Med; 1991 Jan; 36(1):21-6. PubMed ID: 1706779
[TBL] [Abstract][Full Text] [Related]
17. Cross-reactivity of a commercial chemiluminescence immunoassay for human chorionic gonadotropin with the free beta-subunit.
Luppa P; Spöttl G; Saller B; Neumeier D; Mann K
J Biolumin Chemilumin; 1992 Jul; 7(3):195-201. PubMed ID: 1381136
[TBL] [Abstract][Full Text] [Related]
18. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
[TBL] [Abstract][Full Text] [Related]
19. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
[TBL] [Abstract][Full Text] [Related]
20. Serum progesterone monitoring in post-molar surveillance.
Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]